
|Videos|October 19, 2021
Dr. Chin discusses advantages of Zenflow Spring System for BPH
Author(s)Urology Times staff
Advertisement
In this video, Peter Chin, MD, discusses the findings of the study, “Evolution of the Zenflow Spring System: A novel nitinol implant for benign prostatic hyperplasia (BPH),” presented at the 2021 American Urological Association Annual Meeting. He also discusses the investigational Zenflow Spring System’s associated advantages from the study. Chin is an associate professor at the University of Wollongong, New South Wales, Australia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical tips for AE management with the gemcitabine intravesical system
2
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
3
Study to assess adaptive-dosed 177Lu-DOTA-HYNIC-panPSMA in mHSPC
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5










